Tandem Diabetes Care Reports Second Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Tandem Diabetes Care (TNDM) PT Raised to $28 at Cowen
July 31, 2018 6:25 AM EDTCowen raised its price target on Tandem Diabetes Care (NASDAQ: TNDM) to $28.00 (from $25.00) while maintaining an Outperform rating following beat and raise.
Analyst Doug Schenkel commented, "TNDM posted a big revenue beat and guidance raise; we expect upside to continue through 2019/2020 and increased... More
Tandem Diabetes (TNDM) Misses Q2 EPS by 82c, Revenues Beat; Offers FY18 Revenue Outlook
July 30, 2018 4:16 PM EDTTandem Diabetes (NASDAQ: TNDM) reported Q2 EPS of ($1.17), $0.82 worse than the analyst estimate of ($0.35). Revenue for the quarter came in at $34.1 million versus the consensus estimate of $29.67 million.
Second Quarter 2018 Results
In comparing the second quarter of 2018 to the same period of 2017:
Pump shipments increased 59 percent to 5,447 pumps from 3,427 pumpsSales... More